Dyslipidaemia management: how the 2025 ESC/EAS guidelines change daily practice
The 2025 focused update of the 2019 ESC/EAS guidelines on the management of dyslipidaemias introduces important updates that directly impact cardiovascular risk assessment and lipid-lowering strategies in daily clinical practice. In this educational webinar, experts will provide an overview of the key guideline updates and discuss their practical implementation in real-world patient care.
🎓 Accreditation points available for participants
👩⚕️ Please note: this content is intended for healthcare professionals only
🎓 Accreditation points available for participants
👩⚕️ Please note: this content is intended for healthcare professionals only
Practical information
Date: 29 April 2026
Time: 19:00-20:00
Format: Live online webinar
Target audience: Cardiologists and healthcare professionals involved in cardiovascular prevention and dyslipidaemia management
Participation: Free, but registration is required.
Certificate of attendance will be available after the webinar.
Time: 19:00-20:00
Format: Live online webinar
Target audience: Cardiologists and healthcare professionals involved in cardiovascular prevention and dyslipidaemia management
Participation: Free, but registration is required.
Certificate of attendance will be available after the webinar.
Learning objectives
After participating in this webinar, attendees will be aware of:
- Guideline updates on cardiovascular risk estimation and implications for dyslipidaemia management;
- Guideline updates regarding lipoprotein(a);
- New recommendations on LDL-C-lowering therapies;
- Guideline recommendations on combination of lipid-lowering therapies; and
- Integration of the updated recommendations into daily clinical practice for cardiovascular prevention.
Faculty
Moderator:
Dr Jannik Heemann, AZ Jan Portaels-Algemeen Ziekenhuis Vilvoorde
Speakers:
Dr Fabian Demeure, CHU UCL Namur
Dr Eleftherios Choustoulakis, UZ Brussels
Dr Jannik Heemann, AZ Jan Portaels-Algemeen Ziekenhuis Vilvoorde
Speakers:
Dr Fabian Demeure, CHU UCL Namur
Beyond the score - cardiovascular risk assessment in the 2025 ESC/EAS era
Dr Eleftherios Choustoulakis, UZ Brussels
Lp(a): “little letter, capital value”
Dr Tijs Bringmans, AZ Sint-Maarten
Route 55 – combination therapy from start to finish
Dyslipidaemia management: how the 2025 ESC/EAS guidelines change daily practice
The 2025 focused update of the 2019 ESC/EAS guidelines on the management of dyslipidaemias introduces important updates that directly impact cardiovascular risk assessment and lipid-lowering strategies in daily clinical practice. In this educational webinar, experts will provide an overview of the key guideline updates and discuss their practical implementation in real-world patient care.
Moderator:
Moderator:
Dr Jannik Heemann, AZ Jan Portaels-Algemeen Ziekenhuis Vilvoorde
Speakers:
Dr Fabian Demeure, CHU UCL Namur
Dr Eleftherios Choustoulakis, UZ Brussels
Dr Tijs Bringmans, AZ Sint-Maarten
Register via the form on the right to get free access to the videos. 👉
